Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview
Authors
Keywords
Chemotherapy-induced peripheral neuropathy, CIPN, Neuropathy
Journal
SUPPORTIVE CARE IN CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-31
DOI
10.1007/s00520-019-04987-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent developments of novel pharmacologic therapeutics for prevention of chemotherapy-induced peripheral neuropathy
- (2019) Shuiying Hu et al. CLINICAL CANCER RESEARCH
- Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
- (2019) Alex Molassiotis et al. Brain and Behavior
- Pharmacogenomics of vincristine-induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes
- (2018) Galen E B Wright et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity
- (2018) Alix F. Leblanc et al. JOURNAL OF CLINICAL INVESTIGATION
- Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci
- (2018) Lara E. Sucheston-Campbell et al. Pharmacogenetics and Genomics
- Using stratified medicine to understand, diagnose, and treat neuropathic pain
- (2018) Andreas C. Themistocleous et al. PAIN
- Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia
- (2018) Nathalie K. Zgheib et al. Pharmacogenetics and Genomics
- A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer
- (2018) Hailey W. Bulls et al. GYNECOLOGIC ONCOLOGY
- Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patients
- (2017) Chiara Campo et al. HEMATOLOGICAL ONCOLOGY
- Increased risk of paclitaxel-induced peripheral neuropathy in patients using clopidogrel: a retrospective pilot study
- (2017) Mitsuhiro Matsuo et al. Journal of Anesthesia
- CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer
- (2017) Jodi L. Skiles et al. PEDIATRIC BLOOD & CANCER
- Disease burden and pain in obese cancer patients with chemotherapy-induced peripheral neuropathy
- (2017) Emily Cox-Martin et al. SUPPORTIVE CARE IN CANCER
- Impact of chemotherapy-induced neurotoxicities on adult cancer survivors’ symptom burden and quality of life
- (2017) Christine Miaskowski et al. Journal of Cancer Survivorship
- Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy
- (2017) Annelot G.J. van Rosssum et al. Oncotarget
- Single nucleotide polymorphisms of nucleotide excision repair pathway are significantly associated with outcomes of platinum-based chemotherapy in lung cancer
- (2017) Xiao Song et al. Scientific Reports
- Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
- (2017) Hana Starobova et al. Frontiers in Molecular Neuroscience
- Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103.
- (2017) B. P. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Biallelic Mutations of VAC14 in Pediatric-Onset Neurological Disease
- (2016) Guy M. Lenk et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
- (2016) M. Joerger et al. ANNALS OF ONCOLOGY
- Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients
- (2016) Siu W Lam et al. BRITISH JOURNAL OF CANCER
- A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
- (2016) F. Magrangeas et al. CLINICAL CANCER RESEARCH
- Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy
- (2016) D. L. Hertz et al. CLINICAL CANCER RESEARCH
- An Inherited Genetic Variant inCEP72Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia
- (2016) W Stock et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array
- (2016) Ramón García-Sanz et al. HEMATOLOGICAL ONCOLOGY
- Sensitivity analysis of gene ranking methods in phenotype prediction
- (2016) Enrique J. deAndrés-Galiana et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials
- (2016) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations
- (2016) Anna Hucke et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population
- (2016) Angela Gutierrez-Camino et al. Pharmacogenetics and Genomics
- Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel
- (2016) Kuş Tulay et al. OncoTargets and Therapy
- Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans
- (2016) Bryan P. Schneider et al. Oncotarget
- Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)
- (2016) Ganesh K. Boora et al. Cancer Medicine
- Docetaxel-induced neuropathy: A pharmacogenetic case-control study of 150 women with early-stage breast cancer
- (2015) Lise Eckhoff et al. ACTA ONCOLOGICA
- Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review
- (2015) C.N. Frederiks et al. CANCER TREATMENT REVIEWS
- Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199
- (2015) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Candidate pathway-based genetic association study of platinum and platinum–taxane related toxicity in a cohort of primary lung cancer patients
- (2015) Cassandra Johnson et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Association of the Charcot–Marie–Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)
- (2015) Ganesh K. Boora et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- RWDD3andTECTAvariants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1
- (2014) Amit A. Kulkarni et al. ACTA ONCOLOGICA
- Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy
- (2014) Daniel L. Hertz et al. BREAST CANCER RESEARCH AND TREATMENT
- Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia
- (2014) Quentin Chalret du Rieu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The genetic variants underlying breast cancer treatment-induced chronic and late toxicities: A systematic review
- (2014) Terence Ng et al. CANCER TREATMENT REVIEWS
- Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel
- (2014) J. E. Abraham et al. CLINICAL CANCER RESEARCH
- Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
- (2014) Marta Seretny et al. PAIN
- XRCC1 and XPD genetic polymorphisms and clinical outcomes of gastric cancer patients treated with oxaliplatin-based chemotherapy: a meta-analysis
- (2014) Xin Zhang et al. TUMOR BIOLOGY
- Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study
- (2013) A. Custodio et al. ANNALS OF ONCOLOGY
- Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
- (2013) J. A. Sprowl et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study
- (2013) J. S. Gewandter et al. SUPPORTIVE CARE IN CANCER
- GWAS-based association betweenRWDD3andTECTAvariants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients
- (2012) Troels K. Bergmann et al. ACTA ONCOLOGICA
- Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity
- (2011) Romain Guilhaumou et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacometabonomic Profiling as a Predictor of Toxicity in Patients with Inoperable Colorectal Cancer Treated with Capecitabine
- (2011) A. Backshall et al. CLINICAL CANCER RESEARCH
- Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
- (2011) David C. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Vincristine pharmacodynamics and pharmacogenetics in children with cancer: A limited-sampling, population modelling approach
- (2011) Andrew S Moore et al. JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
- (2011) Philippe Moreau et al. LANCET ONCOLOGY
- Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide
- (2011) María Teresa Cibeira et al. LEUKEMIA RESEARCH
- Genetic variation associated with bortezomib-induced peripheral neuropathy
- (2011) Reyna Favis et al. Pharmacogenetics and Genomics
- Risk of Chemotherapy-Induced Peripheral Neuropathy in Large Population-Based Cohorts of Elderly Patients With Breast, Ovarian, and Lung Cancer
- (2010) Zhannat Nurgalieva et al. AMERICAN JOURNAL OF THERAPEUTICS
- Effect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized study
- (2010) Keiichiro Ishibashi et al. International Journal of Clinical Oncology
- Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia
- (2010) Akinbode Egbelakin et al. PEDIATRIC BLOOD & CANCER
- STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement
- (2009) Julian Little et al. PLOS MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started